Stocks and Finance

Geron

Geron 1/5/2012

22:50 : Geron hires new CFO after awarding bonus to outgoing CFO - A second Geron Corp. executive who had received a six-figure 2011 bonus late last month has left the drug-development company. Menlo Park-based Geron (NASDAQ: GERN) said Thursday that it hired Graham Cooper as chief ...
Source : bizjournals-com
17:59 : Geron exec leaves with severance, consulting deal - Jane Lebkowski, one of four Geron Corp. executives to pull down six-figure bonuses late last month, left the company Dec. 31 with $368,500 in severance pay, 12 months of health care coverage and an extension on exercisable stock options. ...
Source : bizjournals-com

Geron 12/23/2011

17:57 : Four Geron execs split $600,000 in cash bonuses - Geron Corp., which last month pulled out of the stem cell business, awarded four executives more than $600,000 in cash bonuses. The Menlo Park-based company (NASDAQ: GERN) said President and Chief Financial Officer David Greenwood was awarded ...
Source : bizjournals-com

Geron 11/15/2011

12:44 : Geron halts stem cell work, cuts 38% of workforce - Geron Corp., the company that was conducting the first U.S.-authorized trial of human embryonic stem cells, is ending the program to focus on its cancer drugs. The Menlo Park company will eliminate 66 full-time jobs, or...
Source : sfgate-com

Geron 11/14/2011

19:58 : Stem cell pioneer Geron to focus on cancer, cut 66 jobs - Pioneering stem cell drug developer Geron Corp. said it will axe 66 jobs, halt its stem cell R&D programs and seek buyers for those assets. The Menlo Park company (NASDAQ: GERN) said it will concentrate on cancer treatments that could produce ...
Source : bizjournals-com
19:21 : Geron halting stem cell research, laying off staff - MENLO PARK, Calif. (AP) -- Money troubles have forced the first company doing a government-approved test of embryonic stem cell therapy to discontinue further stem cell programs and lay off much of its staff....
Source : usnews-com

Geron 9/30/2011

00:37 : Geron Names John Scarlett as CEO - Geron Corp (GERN.O), which is conducting the first U.S.-approved human embryonic stem cell trial, has named John Scarlett as its chief executive officer, replacing interim CEO David Greenwood, who will leave the biotech company at the end ...
Source : ibtimes-com
actualidad Geron -
Logo Geron

Geron by date


Biotechnology

Pharmaceuticals

Medical Supplies

Medical Equipment

Health Care Providers

Copyright © 2009 Finaperf.com - Exchange rate - Investir - Stock Exchange - Börse - Finanças - Bolsa - Tous droits réservés
Site édité par Yanga.net - Contacts